PFW Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

PFW Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,295	Closed	-$821K	–	130
2025 Q4	$821K	Hold	26,295	–	–	0.25%	69
2025 Q3	$531K	Hold	26,295	–	–	0.16%	84
2025 Q2	$441K	Buy	26,295 +313	+1%	+$5.05K	0.14%	90
2025 Q1	$399K	Sell	25,982 -8	-0%	-$143	0.13%	91
2024 Q4	$573K	Buy	+25,990	New	+$473K	0.18%	82
2024 Q2	$422K	Buy	25,982 +543	+2%	+$8.36K	0.13%	90
2024 Q1	$359K	Buy	25,439 +121	+0.5%	+$1.52K	0.11%	96
2023 Q4	$264K	Buy	25,318 +318	+1%	+$2.97K	0.08%	105
2023 Q3	$255K	Hold	25,000	–	–	0.09%	103
2023 Q2	$245K	Buy	+25,000	New	+$203K	0.08%	109
2019 Q3	$468K	Buy	+25,982	New	+$199K	0.14%	90

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

PFW Advisors's TEVA Position: Q1 2026 in Review

PFW Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2026, closing a stake of 26,295 shares — an estimated $821K sold.

PFW Advisors first reported a position in TEVA in Q3 2019 and held it in 11 quarters. The position peaked at $821K in Q4 2025. 653 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

PFW Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2026 after selling out during the quarter.
PFW Advisors sold 26,295 Teva Pharmaceutical Industries Limited shares in Q1 2026, an estimated $821K.
PFW Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q3 2019 and held it in 11 quarters.
PFW Advisors's Teva Pharmaceutical Industries Limited position peaked at $821K in Q4 2025.
653 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2026.

Based on PFW Advisors's 13F filing for Q1 2026, filed 10 Apr 2026.